Thomas Brumby

This inventor holds 21 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Schering Aktiengesellschaft, Piramal Imaging Sa, Bayer Pharma Aktiengesellschaft. Active years: 1991-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Brumby. Retrieved from https://idiyas.com/inventor/thomas-brumby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 10)

% Patents Active = 76.2

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 20)

Average Co-Inventor Count = 6.3

ph-index = 7

Forward Citations = 135(Granted Patents)

Company Filing History:

9 out of 1,409

Schering Aktiengesellschaft

Bayer Pharma Aktiengesellschaft

patents

4. 3 out of 192

Bayer Schering Pharma Ag

patents

5. 2 out of 12,268

Bayer Aktiengesellschaft

patents

6. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

Contrast Media

Imaging Agents

Central Nervous System

Tumor Diagnosis

CDK-Inhibitory Pyrimidines

Peptide Compounds

Ergolines

Heteroaromatic Compounds

Radiolabeled Amino Acids

Glucocorticoids

Perfluoroalkyl-Containing Complexes

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12303573 - Formulation of contrast media and process of preparation thereof (2025-05-20),

2. 11944690 - Formulation of contrast media and process of preparation thereof (2024-04-02),

3. 10266506 - Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors (2019-04-23),

4. 10023539 - Aryl-cyanoguanidine compounds (2018-07-17),

5. 9682944 - Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors (2017-06-20),

6. 9238631 - Radiolabeled amino acids for diagnostic imaging (2016-01-19),

7. 8784775 - Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors (2014-07-22),

8. 8557776 - [object Object] (2013-10-15),

9. 7618957 - Perfluoroalkyl-containing complexes, process for their production as well as their use (2009-11-17),

10. 7598260 - CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents (2009-10-06),

11. 7291624 - CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents (2007-11-06),

12. 7235561 - Compound and a composition including such a compound (2007-06-26),

13. 6284779 - Heteroaromatic compounds (2001-09-04),

14. 5616573 - Glucocorticoids (1997-04-01),

15. 5547958 - N-(8.alpha.-ergolinyl)-amides (1996-08-20),

Title: Thomas Brumby: Pioneering Innovations in Berlin

Introduction:

Thomas Brumby is a visionary inventor based in Berlin, DE, whose remarkable contributions have led to the successful development of numerous groundbreaking patents in the field of healthcare and medical imaging. With a portfolio of 20 patents, Brumby's work has significantly advanced the fields of contrast media formulations and compounds for diagnosing central nervous system diseases and tumors.

Latest Patents:

Brumby's latest patents showcase his expertise in formulating contrast media and developing compounds for diagnosing and treating diseases of the central nervous system or tumors. His innovative liquid pharmaceutical formulation comprising a DOSA-derived tetra-chelate of formula (I) has paved the way for improved imaging techniques, offering enhanced precision and accuracy in medical diagnostics.

Career Highlights:

Throughout his illustrious career, Brumby has made significant strides in the pharmaceutical industry, working with renowned companies such as Schering Aktiengesellschaft and Piramal Imaging SA. His innovative research and development efforts have earned him a reputation as a leading expert in the field, driving advancements in medical imaging technologies and healthcare solutions.

Collaborations:

Brumby's collaborations with esteemed coworkers such as Gerhard Sauer and Helmut Wachtel have played a pivotal role in his success as an inventor. Together, they have shared insights, knowledge, and expertise, leading to the successful implementation of groundbreaking projects and patents that have revolutionized the healthcare industry.

Conclusion:

In conclusion, Thomas Brumby's dedication to innovation and his relentless pursuit of excellence have positioned him as a trailblazer in the field of healthcare and medical imaging. His inventive spirit and collaborative approach have not only enhanced diagnostic and treatment capabilities but have also inspired future generations of inventors to push the boundaries of what is possible in the realm of medical innovation.

Profile summary based on public USPTO records.